- LISA FISHER
The Division of Genetics and Metabolism conducts a case conference on the 1st and 3rd Wednesday of every month. Each session includes the presentation of clinical cases that are either diagnostic dilemmas or illustrate an important concept in clinical care. Presentations generally include background information for understanding and presentation of the case followed by discussion and Q/A.
Division of Genetics and Metabolism staff and students including physicians, genetic counselors, nurses, dieticians, clinic coordinators and genetics trainees (rotating residents/medical students, medical genetic fellows, genetic counseling students), and State Lab of Hygiene faculty and staff including cytogeneticists, molecular geneticists, lab directors and fellows.
|Catherine Reiser, MS, CGC, Chair||Dave Wargowski, MD||Lisa Fisher, BA, Coordinator|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
As a result of case conference participation, learners will be able to:
- Translate new knowledge and tools into their clinical practice.
- Discuss various approaches to diagnostic dilemmas.